Glucagon-like peptide 1 protects microvascular endothelial cells by inactivating the PARP-1/iNOS/NO pathway.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Molecular and Cellular Endocrinology

• Publication date

  2011-06-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.mce.2011.03.007PMID 21458523
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor.

  2010cited by this paper
• Insulin resistance, lipotoxicity and endothelial dysfunction.

  2010cited by this paper
• Serum Oxidized-LDL is Associated with Diabetes Duration Independent of Maintaining Optimized Levels of LDL-Cholesterol

  2010cited by this paper
• The incretin system and its role in type 2 diabetes mellitus.

  2009cited by this paper
• From Endothelial to β Cells: Insights into Pancreatic Islet Microendothelium

  2008cited by this paper
• The Potential Beneficial Role of Glucagon-like Peptide-1 in Endothelial Dysfunction and Heart Failure Associated with Insulin Resistance

  2008cited by this paper
• Excessive Islet NO Generation in Type 2 Diabetic GK Rats Coincides with Abnormal Hormone Secretion and Is Counteracted by GLP-1

  2008cited by this paper
• Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia

  2008cited by this paper
• From endothelial to beta cells: insights into pancreatic islet microendothelium.

  2008cited by this paper
• Islet Vasculature as a Regulator of Endocrine Pancreas Function

  2007cited by this paper
• Nitric Oxide-dependent Negative Feedback of PARP-1 trans-Activation of the Inducible Nitric-oxide Synthase Gene*

  2006cited by this paper
• The pancreatic islet endothelial cell: emerging roles in islet function and disease.

  2006cited by this paper
• Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease.

  2006cited by this paper
• The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

  2006cited by this paper
• The pancreatic islet endothelial cell: emerging roles in islet function and disease.

  2006cited by this paper
• Long-term high-fat diet induces pancreatic injuries via pancreatic microcirculatory disturbances and oxidative stress in rats with hyperlipidemia.

  2006cited by this paper
• Nitric oxide, hypoxia, and superoxide: the good, the bad, and the ugly!

  2005cited by this paper
• Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

  2004cited by this paper
• Five stages of evolving beta-cell dysfunction during progression to diabetes.

  2004cited by this paper
• Microvascular development: learning from pancreatic islets

  2004cited by this paper
• Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications

  2004cited by this paper
• Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation.

  2004cited by this paper
• Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2.

  2003cited by this paper
• Total parenteral nutrition-stimulated activity of inducible nitric oxide synthase in rat pancreatic islets is suppressed by glucagon-like peptide-1.

  2003cited by this paper
• Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation.

  2002cited by this paper
• Biological actions and therapeutic potential of the glucagon-like peptides.

  2002cited by this paper
• Endothelial Cell Dysfunction Leading to Diabetic Nephropathy: Focus on Nitric Oxide

  2001cited by this paper
• Induction of Pancreatic Differentiation by Signals from Blood Vessels

  2001cited by this paper
• High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3.

  2000cited by this paper
• High Glucose–Induced Apoptosis in Human Endothelial Cells Is Mediated by Sequential Activations of c-Jun NH2-Terminal Kinase and Caspase-3

  2000cited by this paper
• Endothelial cells in physiology and in the pathophysiology of vascular disorders.

  1998cited by this paper
• DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite.

  1996cited by this paper
• High-Glucose–Triggered Apoptosis in Cultured Endothelial Cells

  1995cited by this paper
• The Pancreas : biology, pathobiology, and disease

  1993cited by this paper
• Pathobiology of Endothelial and Other Vascular Cells in Diabetes Mellitus: Call for Data

  1991cited by this paper
• Localization of Saturable CCK Binding Sites in Rat Pancreatic Islets by Light and Electron Microscope Autoradiography

  1985cited by this paper

• Tirzepatide: A Novel Cardiovascular Protective Agent in Type 2 Diabetes Mellitus and Obesity.

  2024cites this paper
• ADP-ribosylation, a multifaceted modification: functions and mechanisms in aging and aging-related diseases.

  2024influential citation
• The blood pressure lowering effects of glucagon-like peptide-1 receptor agonists: A mini-review of the potential mechanisms.

  2023cites this paper
• Emerging roles of TFE3 in metabolic regulation

  2023cites this paper
• PARPs in lipid metabolism and related diseases.

  2021cites this paper
• Fructo-oligosaccharides alleviate inflammation-associated apoptosis of GLP-1 secreting L cells via inhibition of iNOS and cleaved caspase-3 expression.

  2020cites this paper
• GLP-1-Induced AMPK Activation Inhibits PARP-1 and Promotes LXR-Mediated ABCA1 Expression to Protect Pancreatic β-Cells Against Cholesterol-Induced Toxicity Through Cholesterol Efflux

  2020cites this paper
• The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism

  2020cites this paper
• SIRT6 inhibits cholesterol crystal-induced vascular endothelial dysfunction via Nrf2 activation.

  2019cites this paper
• Liraglutide ameliorates palmitate-induced oxidative injury in islet microvascular endothelial cells through GLP-1 receptor/PKA and GTPCH1/eNOS signaling pathways.

  2019cites this paper
• Exenatide mitigates inflammation and hypoxia along with improved angiogenesis in obese fat tissue.

  2019cites this paper
• Metabolic roles of poly(ADP-ribose) polymerases.

  2017cites this paper
• Vascular failure and recent anti-diabetic drugs

  2017cites this paper
• 1,25(OH)2D3 improves cardiac dysfunction, hypertrophy, and fibrosis through PARP1/SIRT1/mTOR‐related mechanisms in type 1 diabetes

  2017cites this paper
• Poly(ADP-Ribose) Polymerases in Aging - Friend or Foe?

  2016cites this paper
• Vascular Biology of Glucagon Receptor Superfamily Peptides: Mechanistic and Clinical Relevance.

  2016cites this paper
• GLP-1 Induces Barrier Protective Expression in Brunner's Glands and Regulates Colonic Inflammation

  2016cites this paper
• Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance.

  2015cites this paper
• Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells

  2015cites this paper
• Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity

  2015cites this paper
• Association of low GLP-1 with oxidative stress is related to cardiac disease and outcome in patients with type 2 diabetes mellitus: a pilot study.

  2015cites this paper
• PEGylated Exendin-4, a Modified GLP-1 Analog Exhibits More Potent Cardioprotection than Its Unmodified Parent Molecule on a Dose to Dose Basis in a Murine Model of Myocardial Infarction

  2015cites this paper
• Do incretins improve endothelial function?

  2014cites this paper
• Small Islets Transplantation Superiority to Large Ones: Implications from Islet Microcirculation and Revascularization

  2014cites this paper
• Poly(ADP‐ribose) Polymerase 1 (PARP1) in Atherosclerosis: From Molecular Mechanisms to Therapeutic Implications

  2014cites this paper
• Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases.

  2013cites this paper
• Direct cardiovascular effects of glucagon like peptide-1

  2013cites this paper
• Glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1: Incretin actions beyond the pancreas

  2013influential citation
• Glucagon-like peptide-1 preserves coronary microvascular endothelial function after cardiac arrest and resuscitation: potential antioxidant effects.

  2013cites this paper
• Direct cardiovascular effects of glucagon like

  2013cites this paper
• The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways

  2012cites this paper
• Endogenous Bioactive Peptides as Potential Biomarkers for Atherosclerotic Coronary Heart Disease

  2012cites this paper
• Glucose-Dependent Insulinotropic Polypeptide

  2011cites this paper